Exogenous α-synuclein decreases raft partitioning of Cav2.2 channels inducing dopamine release

Journal of Neuroscience

Volumn 34, Issue 32, 2014, Pages 10603-10615

  Ronzitti, Giuseppe ^a,f   Bucci, Giovanna ^b,g   Emanuele, Marco ^a   Leo, Damiana ^a   Sotnikova, Tatyana D ^a   Mus, Liudmila V ^a   Soubrane, Camille H ^b   Dallas, Mark L ^b   Thalhammer, Agnes ^a   Cingolani, Lorenzo A ^a   Mochida, Sumiko ^c   Gainetdinov, Raul R ^a,d,e   Stephens, Gary J ^b   Chieregatti, Evelina ^a  

^a ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

^b UNIVERSITY OF READING   (United Kingdom)

^c TOKYO MEDICAL UNIVERSITY   (Japan)

^d SKOLKOVO INSTITUTE OF SCIENCE AND TECHNOLOGY   (Russian Federation)

^e ST PETERSBURG STATE UNIVERSITY   (Russian Federation)

^f GÉNÉTHON   (France)

^g UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Dopamine release; Extracellular alpha synuclein; Lipid rafts

Indexed keywords

CAV2.2 CHANNELS; DOPAMINE RELEASE; EXTRACELLULAR ALPHA-SYNUCLEIN; LIPID RAFTS;

ALPHA-SYNUCLEIN; ANILINE COMPOUNDS; ANIMALS; ANTIBODIES; CALCIUM CHANNELS, N-TYPE; CELLS, CULTURED; CEREBRAL CORTEX; DOPAMINE; EMBRYO, MAMMALIAN; EXCITATORY POSTSYNAPTIC POTENTIALS; MALE; MEMBRANE MICRODOMAINS; MEMBRANE POTENTIALS; NEURONS; RATS; RATS, WISTAR; SODIUM CHANNEL BLOCKERS; SUPERIOR CERVICAL GANGLION; SYNAPTIC TRANSMISSION; SYNAPTOPHYSIN; XANTHENES;

EID: 84905695099     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.0608-14.2014     Document Type: Article

References (75)

1. Adamczyk A, Strosznajder JB (2006) Alpha-synuclein potentiates Ca2+ influx through voltage-dependent Ca2+ channels. Neuroreport 17:1883-1886. CrossRef Medline
2. Bergquist F., Jonason J, Pileblad E, Nissbrandt H (1998) Effects of local administration of L-, N-, and P/Q-type calcium channel blockers on spontaneous dopamine release in the striatum and the substantia nigra: a microdialysis study in rat. J Neurochem 70:1532-1540. CrossRef Medline
3. Bezprozvanny I., Scheller RH, Tsien RW (1995) Functional impact of syntaxin on gating of N-type and Q-type calcium channels. Nature 378:623-626. CrossRef Medline
4. Bickel P. E, Scherer PE, Schnitzer JE, Oh P, Lisanti MP, Lodish HF (1997) Flotillin and epidermal surface antigen define a new family of caveolaeassociated integral membrane proteins. J Biol Chem 272:13793-13802. CrossRef Medline
5. Borghi R., Marchese R, Negro A, Marinelli L, Forloni G, Zaccheo D, Abbruzzese G, Tabaton M (2000) Full length alpha-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjects. Neurosci Lett 287:65-67. CrossRef Medline
6. Brewer G. J (1997) Isolation and culture of adult rat hippocampal neurons. J Neurosci Methods 71:143-155. CrossRef Medline
7. Bucci G., Mochida S, Stephens GJ (2011) Inhibition of synaptic transmission and G protein modulation by synthetic CaV2.2 Ca(2)+ channel peptides. J Physiol 589:3085-3101. CrossRef Medline
8. Butchbach M. E, Tian G, Guo H, Lin CL (2004) Association of excitatory amino acid transporters, especially EAAT2, with cholesterol-rich lipid raft microdomains: importance for excitatory amino acid transporter localization and function. J Biol Chem 279:34388-34396. CrossRef Medline
9. Catterall W. A (2000) Structure and regulation of voltage-gated Ca2+ channels. Annu Rev Cell Dev Biol 16:521-555. CrossRef Medline
10. Chiba-Falek O., Lopez GJ, Nussbaum RL (2006) Levels of alpha-synuclein mRNA in sporadic Parkinson disease patients. Mov Disord 21:1703-1708. CrossRef Medline
11. Chung C. Y, Koprich JB, Siddiqi H, Isacson O (2009) Dynamic changes in presynaptic and axonal transport proteins combined with striatal neuroinflammation precede dopaminergic neuronal loss in a rat model of AAV-synucleinopathy. J Neurosci 29:3365-3373. CrossRef Medline
12. Crowet J. M, Lins L, Dupiereux I, Elmoualija B, Lorin A, Charloteaux B, Stroobant V., Heinen E, Brasseur R (2007) Tilted properties of the 67-78 fragment of alpha-synuclein are responsible for membrane destabilization and neurotoxicity. Proteins 68:936-947. CrossRef Medline
13. Damier P., Hirsch EC, Agid Y, Graybiel AM (1999) The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry. Brain 122:1421-1436. CrossRef Medline
14. Davies A., Douglas L, Hendrich J, Wratten J, Tran Van Minh A, Foucault I, Koch D., Pratt WS, Saibil HR, Dolphin AC (2006) The calcium channel alpha2delta-2 subunit partitions with CaV2.1 into lipid rafts in cerebellum: implications for localization and function. J Neurosci 26:8748-8757. CrossRef Medline
15. Davies J. N, Jarvis SE, Zamponi GW (2011) Bipartite syntaxin 1A interactions mediate CaV2.2 calcium channel regulation. Biochem Biophys Res Commun 411:562-568. CrossRef Medline
16. Decressac M., Mattsson B, Lundblad M, Weikop P, Björklund A (2012) Progressive neurodegenerative and behavioural changes induced by AAVmediated overexpression of alpha-synuclein in midbrain dopamine neurons. Neurobiol Dis 45:939-953. CrossRef Medline
17. Dodge F. A Jr, Rahamimoff R (1967) On the relationship between calcium concentration and the amplitude of the end-plate potential. J Physiol 189:90P-92P. Medline
18. Dolphin A. C (1996) Facilitation of Ca2+ current in excitable cells. Trends Neurosci 19:35-43. CrossRef Medline
19. Dolphin A. C (2003) G protein modulation of voltage-gated calcium channels. Pharmacol Rev 55:607-627. CrossRef Medline
20. Dolphin A. C (2009) Calcium channel diversity: multiple roles of calcium channel subunits. Curr Opin Neurobiol 19:237-244. CrossRef Medline
21. Dolphin A. C (2012) Calcium channel auxiliary alpha2delta and beta subunits: trafficking and one step beyond. Nat Rev Neurosci 13:542-555. CrossRef Medline
22. El-Agnaf O. M, Salem SA, Paleologou KE, Cooper LJ, Fullwood NJ, Gibson MJ, Curran M. D, Court JA, Mann DM, Ikeda S, Cookson MR, Hardy J, Allsop D (2003) Alpha-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma. FASEB J 17: 1945-1947. CrossRef Medline
23. Fantini J., Carlus D, Yahi N (2011) The fusogenic tilted peptide (67-78) of alpha-synuclein is a cholesterol binding domain. Biochim Biophys Acta 1808:2343-2351. CrossRef Medline
24. Farrer M., Kachergus J, Forno L, Lincoln S, Wang DS, Hulihan M, Maraganore D, Gwinn-Hardy K, Wszolek Z, Dickson D, Langston JW (2004) Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications. Ann Neurol 55:174-179. CrossRef Medline
25. Fortin D. L, Troyer MD, Nakamura K, Kubo S, Anthony MD, Edwards RH (2004) Lipid rafts mediate the synaptic localization of α-synuclein. J Neurosci 24:6715-6723. CrossRef Medline
26. Garner C. C, Kindler S, Gundelfinger ED (2000) Molecular determinants of presynaptic active zones. Curr Opin Neurobiol 10:321-327. CrossRef Medline
27. Goldberg M. S, Fleming SM, Palacino JJ, Cepeda C, Lam HA, Bhatnagar A, Meloni E. G, Wu N, Ackerson LC, Klapstein GJ, Gajendiran M, Roth BL, Chesselet M. F, Maidment NT, Levine MS, Shen J (2003) Parkindeficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. J Biol Chem 278:43628-43635. CrossRef Medline
28. Hansen C., Angot E, Bergström AL, Steiner JA, Pieri L, Paul G, Outeiro TF, Melki R., Kallunki P, Fog K, Li JY, Brundin P (2011) alpha-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells. J Clin Invest 121:715-725. CrossRef Medline
29. Hell J. W, Westenbroek RE, Breeze LJ, Wang KK, Chavkin C, Catterall WA (1996) N-methyl-D-aspartate receptor-induced proteolytic conversion of postsynaptic class C L-type calcium channels in hippocampal neurons. Proc Natl Acad Sci U S A 93:3362-3367. CrossRef Medline
30. Hettiarachchi N. T, Parker A, Dallas ML, Pennington K, Hung CC, Pearson HA, Boyle JP, Robinson P, Peers C (2009) alpha-Synuclein modulation of Ca2+ signaling in human neuroblastoma (SH-SY5Y) cells. J Neurochem 111:1192-1201. CrossRef Medline
31. Jarvis S. E, Zamponi GW (2007) Trafficking and regulation of neuronal voltage-gated calcium channels. Curr Opin Cell Biol 19:474-482. CrossRef Medline
32. Jennings L. J, Xu QW, Firth TA, Nelson MT, Mawe GM (1999) Cholesterol inhibits spontaneous action potentials and calcium currents in guinea pig gallbladder smooth muscle. Am J Physiol 277:G1017-G1026. Medline
33. Kim B. G, Shin DH, Jeon GS, Seo JH, Kim YW, Jeon BS, Cho SS (2000) Relative sparing of calretinin containing neurons in the substantia nigra of 6-OHDA treated rat Parkinsonian model. Brain Res 855:162-165. CrossRef Medline
34. Kordower J. H, Chu Y, Hauser RA, Freeman TB, Olanow CW (2008a) Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease. Nat Med 14:504-506. CrossRef Medline
35. Kordower J. H, Chu Y, Hauser RA, Olanow CW, Freeman TB (2008b) Transplanted dopaminergic neurons develop PD pathologic changes: a second case report. Mov Disord 23:2303-2306. CrossRef Medline
36. Kuhr W. G, Wightman RM (1986) Real-time measurement of dopamine release in rat brain. Brain Res 381:168-171. CrossRef Medline
37. Laemmli U. K (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685. CrossRef Medline
38. Lam H. A, Wu N, Cely I, Kelly RL, Hean S, Richter F, Magen I, Cepeda C, Ackerson L. C, Walwyn W, Masliah E, Chesselet MF, Levine MS, Maidment NT (2011) Elevated tonic extracellular dopamine concentration and altered dopamine modulation of synaptic activity precede dopamine loss in the striatum of mice overexpressing human alpha-synuclein. J Neurosci Res 89:1091-1102. CrossRef Medline
39. Levitan I., Christian AE, Tulenko TN, Rothblat GH (2000) Membrane cholesterol content modulates activation of volume-regulated anion current in bovine endothelial cells. J Gen Physiol 115:405-416. CrossRef Medline
40. Levitan I., Fang Y, Rosenhouse-Dantsker A, Romanenko V (2010) Cholesterol and ion channels. Subcell Biochem 51:509-549. CrossRef Medline
41. Li H., Foss SM, Dobryy YL, Park CK, Hires SA, Shaner NC, Tsien RY, Osborne LC, Voglmaier SM (2011) Concurrent imaging of synaptic vesicle recycling and calcium dynamics. Front Mol Neurosci 4:34. CrossRef Medline
42. Lundbaek J. A, Birn P, Girshman J, Hansen AJ, Andersen OS (1996) Membrane stiffness and channel function. Biochemistry 35:3825-3830. CrossRef Medline
43. Lundblad M., Decressac M, Mattsson B, Björklund A (2012) Impaired neurotransmission caused by overexpression of alpha-synuclein in nigral dopamine neurons. Proc Natl Acad Sci U S A 109:3213-3219. CrossRef Medline
44. Madine J., Doig AJ, Middleton DA (2006) A study of the regional effects of alpha-synuclein on the organization and stability of phospholipid bilayers. Biochemistry 45:5783-5792. CrossRef Medline
45. Martinez J., Moeller I, Erdjument-Bromage H, Tempst P, Lauring B (2003) Parkinson's disease-associated alpha-synuclein is a calmodulin substrate. J Biol Chem 278:17379-17387. CrossRef Medline
46. Mattson M. P (2007) Calcium and neurodegeneration. Aging Cell 6:337-350. CrossRef Medline
47. Melachroinou K., Xilouri M, Emmanouilidou E, Masgrau R, Papazafiri P, Stefanis L., Vekrellis K (2013) Deregulation of calcium homeostasis mediates secreted alpha-synuclein-induced neurotoxicity. Neurobiol Aging 34:2853-2865. CrossRef Medline
48. Mercer A. J, Chen M, Thoreson WB (2011) Lateral mobility of presynaptic L-type calcium channels at photoreceptor ribbon synapses. J Neurosci 31:4397-4406. CrossRef Medline
49. Mercer A. J, Szalewski RJ, Jackman SL, Van Hook MJ, Thoreson WB (2012) Regulation of presynaptic strength by controlling Ca2+ channel mobility: effects of cholesterol depletion on release at the cone ribbon synapse. J Neurophysiol 107:3468-3478. CrossRef Medline
50. Mochida S., Sheng ZH, Baker C, Kobayashi H, Catterall WA (1996) Inhibition of neurotransmission by peptides containing the synaptic protein interaction site of N-type Ca2+ channels. Neuron 17:781-788. CrossRef Medline
51. Mochida S., Westenbroek RE, Yokoyama CT, Itoh K, Catterall WA (2003) Subtype-selective reconstitution of synaptic transmission in sympathetic ganglion neurons by expression of exogenous calcium channels. Proc Natl Acad Sci U S A 100:2813-2818. CrossRef Medline
52. Müller C. S, Haupt A, Bildl W, Schindler J, Knaus HG, Meissner M, Rammner B, Striessnig J, Flockerzi V, Fakler B, Schulte U (2010) Quantitative proteomics of the Cav2 channel nano-environments in the mammalian brain. Proc Natl Acad Sci U S A 107:14950-14957. CrossRef Medline
53. Niwa H., Yamamura K, Miyazaki J (1991) Efficient selection for highexpression transfectants with a novel eukaryotic vector. Gene 108:193-199. CrossRef Medline
54. Nuber S., Harmuth F, Kohl Z, Adame A, Trejo M, Schönig K, Zimmermann F, Bauer C., Casadei N, Giel C, Calaminus C, Pichler BJ, Jensen PH, Müller CP, Amato D, Kornhuber J, Teismann P, Yamakado H, Takahashi R, Winkler J., et al. (2013) A progressive dopaminergic phenotype associated with neurotoxic conversion of alpha-synuclein in BAC-transgenic rats. Brain 136:412-432. CrossRef Medline
55. Phillips P. E, Stamford JA (2000) Differential recruitment of N-, P-and Q-type voltage-operated calcium channels in striatal dopamine release evoked by "regular" and "burst" firing. Brain Res 884:139-146. CrossRef Medline
56. Rituper B., Chowdhury HH, Jorgacevski J, Coorssen JR, Kreft M, Zorec R (2013) Cholesterol-mediated membrane surface area dynamics in neuroendocrine cells. Biochim Biophys Acta 1831:1228-1238. CrossRef Medline
57. Roberts-Crowley M. L, Mitra-Ganguli T, Liu L, Rittenhouse AR (2009) Regulation of voltage-gated Ca2+ channels by lipids. Cell Calcium 45:589-601. CrossRef Medline
58. Robinson P., Etheridge S, Song L, Armenise P, Jones OT, Fitzgerald EM (2010) Formation of N-type (Cav2.2) voltage-gated calcium channel membrane microdomains: lipid raft association and clustering. Cell Calcium 48:183-194. CrossRef Medline
59. Saegusa H., Matsuda Y, Tanabe T (2002) Effects of ablation of N-and R-type Ca(2+) channels on pain transmission. Neurosci Res 43:1-7. CrossRef Medline
60. Satake W., Nakabayashi Y, Mizuta I, Hirota Y, Ito C, Kubo M, Kawaguchi T, Tsunoda T., Watanabe M, Takeda A, Tomiyama H, Nakashima K, Hasegawa K, Obata F, Yoshikawa T, Kawakami H, Sakoda S, Yamamoto M, Hattori N., Murata M, Nakamura Y, et al. (2009) Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat Genet 41:1303-1307. CrossRef Medline
61. Sharon R., Goldberg MS, Bar-Josef I, Betensky RA, Shen J, Selkoe DJ (2001) alpha-Synuclein occurs in lipid-rich high molecular weight complexes, binds fatty acids, and shows homology to the fatty acid-binding proteins. Proc Natl Acad Sci U S A 98:9110-9115. CrossRef Medline
62. Singleton A. B, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, Hulihan M, Peuralinna T, Dutra A, Nussbaum R, Lincoln S, Crawley A, Hanson M, Maraganore D, Adler C, Cookson MR, Muenter M, Baptista M, Miller D, Blancato J, et al. (2003) alpha-Synuclein locus triplication causes Parkinson's disease. Science 302:841. CrossRef Medline
63. Soós J., Engelhardt JI, Siklós L, Havas L, Majtényi K (2004) The expression of PARP, NF-kappa B and parvalbumin is increased in Parkinson disease. Neuroreport 15:1715-1718. CrossRef Medline
64. Spillantini M. G, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) Alpha-synuclein in Lewy bodies. Nature 388:839-840. CrossRef Medline
65. Stea A., Soong TW, Snutch TP (1995) Determinants of PKC-dependent modulation of a family of neuronal calcium channels. Neuron 15:929-940. CrossRef Medline
66. Stephens G. J, Mochida S (2005) G protein {beta}{gamma} subunits mediate presynaptic inhibition of transmitter release from rat superior cervical ganglion neurones in culture. J Physiol 563:765-776. CrossRef Medline
67. Stephens G. J, Brice NL, Berrow NS, Dolphin AC (1998) Facilitation of rabbit alpha1B calcium channels: involvement of endogenous Gbetagamma subunits. J Physiol 509:15-27. CrossRef Medline
68. Stoehr S. J, Campbell GW, Rock DM (1997) Evaluation of N-type Ca2+ channel currents in cultured rat superior cervical ganglion neurons. Drug Dev Res 41:85-90. CrossRef
69. Thoreson W. B, Mercer AJ, Cork KM, Szalewski RJ (2013) Lateral mobility of L-type calcium channels in synaptic terminals of retinal bipolar cells. Mol Vis 19:16-24. Medline
70. Toselli M., Biella G, Taglietti V, Cazzaniga E, Parenti M (2005) Caveolin-1 expression and membrane cholesterol content modulate N-type calcium channel activity in NG108-15 cells. Biophys J 89:2443-2457. CrossRef Medline
71. Venda L. L, Cragg SJ, Buchman VL, Wade-Martins R (2010) alpha-Synuclein and dopamine at the crossroads of Parkinson's disease. Trends Neurosci 33:559-568. CrossRef Medline
72. Volpicelli-Daley L. A, Luk KC, Patel TP, Tanik SA, Riddle DM, Stieber A, Meaney D. F, Trojanowski JQ, Lee VM (2011) Exogenous alphasynuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron 72:57-71. CrossRef Medline
73. Walsh D. M, Selkoe DJ (2004) Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron 44:181-193. CrossRef Medline
74. Westenbroek R. E, Hell JW, Warner C, Dubel SJ, Snutch TP, Catterall WA (1992) Biochemical properties and subcellular distribution of an N-type calcium channel alpha 1 subunit. Neuron 9:1099-1115. CrossRef Medline
75. Wu N., Joshi PR, Cepeda C, Masliah E, Levine MS (2010) Alpha-synuclein overexpression in mice alters synaptic communication in the corticostriatal pathway. J Neurosci Res 88:1764-1776. CrossRef Medline